Education
MD Medicine, University of California (San Francisco), 2000
PhD Epidemiology, University of Washington, 2003
MPH Epidemiology, University of Washington, 2000
Contact
206-667-7444
cili@fhcrc.org
Box 358080
1100 Fairview Ave N., M4-C308
P.O. 19024
Seattle, WA 98109
Research Areas
Research Interests
Dr. Li is a cancer epidemiologist based at the Fred Hutchinson Cancer Research Center with research projects spanning cancer early detection/screening, etiology, and survivorship. He has significant expertise in cancer epidemiology and substantial experience in the design, leadership, and completion of multidisciplinary studies of cancer. Current research projects include: 1. A large population-based study of different molecular subtypes of breast cancer aimed at elucidating their risk factors and identifying novel subtype-specific tumor markers useful for predicting risk of disease recurrence (DOD Collaborative Innovator Award); 2. A nested case-control study of women with DCIS who did and did not go on to develop a second breast cancer aimed at developing novel epidemiologic, clinical, and molecular approaches for guiding clinical decision making for DCIS patients (R01); 3. Discovering and validating novel blood-based markers useful for the early detection of breast, colorectal, and ovarian cancers (U01); 4. Characterizing risk factors for second primary breast, lung, colorectal, and endometrial cancers among breast cancer survivors (R01); and 5. Discovering and validating novel biomarkers useful for assessing risk of recurrence among colorectal cancer survivors (R01 and U01). Selected leaderships activities include: 1. Serving as the co-PI of the Cancer Surveillance System (CSS), the Seattle-Puget Sound Surveillance, Epidemiology and End Results (SEER) cancer registry, 2. Chairing the DOD Breast Cancer Research Program’s Integration Panel (FY 2017), and 3. Co-chairing the 2017 AACR Conference on the Science of Cancer Health Disparities.
Recent Publications (PubMed)
(2024 Nov 13)
Cancer Causes Control
Sheridan L, Pocobelli G, Anderson M, Li CI, Kruse GR, Tiro JA, Kamineni A
(2024 Nov 1)
Cancer Epidemiol Biomarkers Prev
Loroña NC, Othus M, Malone KE, Linden HM, Tang MC, Li CI
(2024 Oct 24)
Cancer Discov
Compton ZT, Mellon W, Harris VK, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez LN, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Li CI, Zehnder A, Graham TA, Troan BV, Harrison TM, Tollis M, Schiffman JD, Aktipis CA, Abegglen LM, Maley CC, Boddy AM
(2024 Oct 12)
Sci Rep 14(1): 23891
Denos M, Sun YQ, Brumpton BM, Li Y, Albanes D, Burnett-Hartman A, Campbell PT, Küry S, Li CI, White E, Samadder JN, Jenkins MA, Mai XM
(2024 Oct 7)
Cancer Epidemiol Biomarkers Prev
Loroña NC, Himbert C, Ose J, Cohen SA, Strehli I, Ulrich CM, Cobos S, Jean-Baptiste E, Bloomer AM, Figueiredo JC, Gigic B, Hardikar S, Karchi M, Mutch M, Peoples AR, Schneider M, Shibata D, Siegel EM, Toriola AT, Wood EH, Li CI
Show complete publication list
In the News
SPH News, 10/30/2015
Huffington Post, 10/16/2015
Crosscut, 08/24/2015
SPH News, 09/26/2014
Cleveland Plain Dealer, 09/05/2014
FHCRC, 09/05/2013
The Seattle Times, 08/05/2013
KUOW, 05/14/2012
FHCRC, 04/10/2012
Business Week, 04/22/2010